133 related articles for article (PubMed ID: 10572614)
1. The clinical utility of the Revised European-American Lymphoma (R.E.A.L.) Classification: preliminary results of a prospective study in patients with non-Hodgkin's lymphoma from a single centre.
Sweetenham JW; Smartt PF; Wilkins BS; Pellatt JC; Smith JL; Ramsay A; Whitehouse JM
Ann Oncol; 1999 Sep; 10(9):1121-4. PubMed ID: 10572614
[TBL] [Abstract][Full Text] [Related]
2. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
3. New REAL clinical entities.
Fisher RI; Miller TP; Grogan TM
Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms.
Lee SS; Cho KJ; Kim CW; Kang YK
Histopathology; 1999 Oct; 35(4):345-54. PubMed ID: 10564389
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
6. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation.
Pittaluga S; Bijnens L; Teodorovic I; Hagenbeek A; Meerwaldt JH; Somers R; Thomas J; Noordijk EM; De Wolf-Peeters C
Blood; 1996 May; 87(10):4358-67. PubMed ID: 8639796
[TBL] [Abstract][Full Text] [Related]
7. Comparison of working formulation and REAL classification of non-Hodgkin's lymphoma: an analysis of 52 cases.
Aggarwal D; Gupta R; Singh S; Kudesia M
Hematology; 2011 Jul; 16(4):195-9. PubMed ID: 21756534
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotype, histopathology and clinical stage: their predictive value in the prognosis of non-Hodgkin's lymphomas.
Mtasiwa DM; Imamura N; Inada T; Takimoto Y; Okada K; Nanba K; Asaoku H; Kuramoto A
Hiroshima J Med Sci; 1990 Dec; 39(4):95-102. PubMed ID: 2086567
[TBL] [Abstract][Full Text] [Related]
9. Head-and-neck stages I and II extranodal non-Hodgkin's lymphomas: real classification and selection for treatment modality.
Sasai K; Yamabe H; Kokubo M; Shibata T; Oya N; Nagata Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):153-60. PubMed ID: 10924985
[TBL] [Abstract][Full Text] [Related]
10. [The morphological diagnosis of malignant non-Hodgkin's lymphomas (lymphosarcomas)].
Probatova NA
Arkh Patol; 1990; 52(9):72-5. PubMed ID: 2270988
[TBL] [Abstract][Full Text] [Related]
11. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
12. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic index from fine needle aspiration cytology as a criterion to predict histologic grade of non-Hodgkin's lymphoma.
Symmans WF; Cangiarella JF; Symmans PJ; Cohen JM; Yee HT; Bennett G; Amorosi EL; Waisman J
Acta Cytol; 2000; 44(2):194-204. PubMed ID: 10740606
[TBL] [Abstract][Full Text] [Related]
14. Practical utility of the revised European-American classification of lymphoid neoplasms for Japanese non-Hodgkin's lymphomas.
Izumo T; Maseki N; Mori S; Tsuchiya E
Jpn J Cancer Res; 2000 Mar; 91(3):351-60. PubMed ID: 10760696
[TBL] [Abstract][Full Text] [Related]
15. Elderly patients with non-Hodgkin's lymphoma: population-based results in The Netherlands.
Maartense E; Hermans J; Kluin-Nelemans JC; Kluin PM; Van Deijk WA; Snijder S; Wijermans PW; Noordijk EM
Ann Oncol; 1998 Nov; 9(11):1219-27. PubMed ID: 9862053
[TBL] [Abstract][Full Text] [Related]
16. Utility of flow cytometry in subtyping composite and sequential lymphoma.
Siebert JD; Mulvaney DA; Vukov AM; Knost JA; King DE; Craig FE
J Clin Lab Anal; 1999; 13(5):199-204. PubMed ID: 10494126
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic analysis of non-Hodgkin's lymphoma.
Muzaffar S; Pervez S; Aijaz F; Aziz SA; Hasan SH
J Pak Med Assoc; 1997 Apr; 47(4):106-9. PubMed ID: 9145638
[TBL] [Abstract][Full Text] [Related]
18. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma.
Auw-Haedrich C; Coupland SE; Kapp A; Schmitt-Gräff A; Buchen R; Witschel H
Br J Ophthalmol; 2001 Jan; 85(1):63-9. PubMed ID: 11133714
[TBL] [Abstract][Full Text] [Related]
19. [Pathological anatomy of primary cerebral lymphoma].
Menet E; Goujon JM; Levillain P; Babin P
Neurochirurgie; 1997; 43(6):357-60. PubMed ID: 9706612
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin's lymphoma by immunohistochemistry.
Akhter A; Saleheen MS; Hussain M; Majid N; Rahman MR; Shermin S; Rajib RC; Huda MM; Haque N
Mymensingh Med J; 2015 Jan; 24(1):108-14. PubMed ID: 25725676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
